Tuesday, August 18 at 16:00 BST / 17:00 CEST / 11:00 EDT / 08:00 PDT

Despite significant strides in prevention, treatment, and PrEP accessibility, infectious diseases like HIV remain a formidable global health challenge. With an estimated 41 million people living with HIV and 1.3 million new infections recorded in 2024, the mandate for timely, accurate diagnosis and immediate linkage to care has never been more critical.

Because early infection is often asymptomatic, routine HIV screening and high-quality lab diagnostics serve as the primary defense in modern virology. Current clinical guidance emphasizes broad screening strategies and the utilization of fourth-generation HIV ag/ab combo assays. These advanced immunoassay HIV solutions are essential for identifying the P24 antigen, HIV-1 antibody, and HIV-2 antibody to detect both established and acute infections at the earliest possible stage.

Join this SelectScience® webinar with our expert panel to explore how innovation can be translated into practice through a comprehensive HIV solution, ensuring confident implementation of an HIV ag/ab combo screen within healthcare systems worldwide.


Webinar details

  • Cost: Free to attend

  • Location: Online

  • Duration: 60 minutes

  • Instruction level: Intermediate

Registration is required to secure your place. If you register but can’t attend live, you will receive a link to the on‑demand recording once it becomes available.

Who should attend?

This event is perfect for:

  • Lab technicians
  • Lab supervisors
  • Lab directors
  • Lab scientists
  • Medical directors
  • Pathologists
  • Infectious disease specialists
  • Microbiologists
  • Primary care physicians
  • Physician assistants
  • Community workers
  • Public health professionals
  • Academic researchers

What will this webinar cover?

This session bridges the gap between laboratory science and clinical outcomes, addressing the critical need for diagnostic precision in HIV monitoring.

  • Epidemiology and screening standards: Explore current global trends and the evolution of the CHIV test and testing algorithms essential for modern clinical practice.
  • Antigen-antibody testing and differentiation: Evaluate the indications, strengths, and limitations of HIV ag/ab combo screens, HIV assay differentiation, and nucleic acid testing (NAT).
  • Workflow best practices: Learn about evidence-based interpretation strategies to navigate result challenges encountered in routine, high-volume laboratory settings.
  • Practical case studies: Gain insights from real-world scenarios to improve diagnostic accuracy and laboratory efficiency.

Key learning objectives:

  • Review current HIV epidemiology, screening expectations, and testing algorithm evolution relevant to clinical and laboratory practice.
  • Compare the indications, strengths, and limitations of generation-based Ag/Ab assays, differentiation testing, and nucleic acid testing in HIV diagnosis.
  • Apply evidence-based interpretation strategies and workflow best practices to real-world HIV diagnostic scenarios encountered in routine laboratory practice.

Accreditation statement

SelectScience is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program. 

Presenters

Monica Gandhi MD, MPH
Monica Gandhi MD, MPH

Professor of Medicine, Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco

Monica Gandhi MD, MPH is a Professor of Medicine and Associate Chief in the Division of HIV, Infectious Diseases, and Global Medicine at the University of California, San Francisco (UCSF). She is also the Director of the UCSF Center for AIDS Research (CFAR) and the HIV Director of the Ward 86 Clinic at San Francisco General Hospital. Her research focuses on HIV treatment and prevention optimization, HIV and women, adherence measurement in HIV and TB, adherence interventions, and optimizing the use of long-acting antiretroviral therapy (ART).

Expertise: HIV • Adherence measurement in HIV and TB • Optimizing the use of long-acting antiretroviral therapy (ART) • HIV and women

Colette Match, PhD, D(ABMM), MPH
Colette Match, PhD, D(ABMM), MPH

Assistant Professor of Clinical Laboratory Medicine, School of Medicine, University of California, San Francisco

Colette Match, PhD, D(ABMM), MPH
Speaker
Assistant Professor of Clinical Laboratory Medicine, School of Medicine, University of California, San Francisco

Colette Match, PhD, D(ABMM), MPH, is an Assistant Professor in the Department of Laboratory Medicine at UCSF and the Director of Microbiology at the UCSF Clinical Lab at Zuckerberg San Francisco General Hospital. Her clinical interests lie in the development and evaluation of microbiology diagnostic assays. She designs and implements rapid molecular tests and next-generation sequencing assays. The emphasis of this work is to solve unmet clinical needs particularly in resource limited settings, and for the improvement of global health. Her academic interests particularly include virology, mucosal immunology, and emerging infectious diseases.

Expertise: Microbiology • Virology • Mucosal immunology • Emerging infectious diseases

Lucy Lawrence
Lucy Lawrence

Science Editor

SelectScience

Register

Note: By completing this form, you will receive a free membership to SelectScience® and The Scientists’ Channel®. SelectScience is a trade organisation, we do not provide services to consumers and membership is for business purposes only. As a member you must provide us with a corporate email address to enable us (and our advertisers and sponsors) to contact you for marketing purposes. You can opt-out of marketing at any time. See our Privacy Policy

(*) denotes required form field(s)

Our registration process uses cookies, by submitting this registration form you agree to our cookie policy.

* Required Fields